Immunological imbalance between IFN-γ and IL-10 levels in the sera of patients with the cardiac form of Chagas disease

Memorias do Instituto Oswaldo Cruz

Volumn 104, Issue 1, 2009, Pages 100-105

  D'Ávila, Daniela A ^a   Guedes, Paulo M M ^b   Castro, Ana M ^c   Gontijo, Eliane D ^a   Chiari, Egler ^a   Galvão, Lúcia M C ^a,d  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^d FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

Author keywords

Chagas disease; Cytokines; IgG isotype; Immunopathogenesis; Trypanosoma cruzi

Indexed keywords

TRYPANOSOMA CRUZI;

EID: 62749151026     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762009000100015     Document Type: Article

References (33)

1. Abel LC, Rizzo LV, Ianni B, Albuquerque F, Bacal F, Carrara D, Bocchi EA, Teixeira HC, Mady C, Kalil J, Cunha-Neto E 2001. Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection. J Autoimmun 17: 99-107.
2. Bahia-Oliveira LM, Gomes JA, Rocha MO, Moreira MC, Lemos EM, Luz ZM, Pereira ME, Coffman RL, Dias JC, Cancado JR, Gazzinelli G, Correa-Oliveira R 1998. IFN-gamma in human Chagas' disease: protection or pathology? Braz J Med Biol Res 31: 127-131.
3. Briere F, Servet-Delprat C, Bridon JM, Saint-Remy JM, Banchereau J 1994. Human interleukin 10 induces naive surface immunoglobulin D+ (sIgD+) B cells to secrete IgG1 and IgG3. J Exp Med 179: 757-762.
4. Camargo ME 1966. Fluorescent antibody test for the serodiagnosis of American trypanosomiasis. Technical modification employing preserved culture forms of Trypanosoma cruzi in a slide test. Rev Inst Med Trop Sao Paulo 8: 227-235.
5. Cerban FM, Gea S, Menso E, Vottero-Cima E 1993. Chagas' disease: IgG isotypes against Trypanosoma cruzi cytosol acidic antigens in patients with different degrees of heart damage. Clin Immunol Immunopathol 67: 25-30.
6. Cordeiro FD, Martins-Filho OA, Da Costa Rocha MO, Adad SJ, Correa-Oliveira R, Romanha AJ 2001. Anti-Trypanosoma cruzi immunoglobulin G1 can be a useful tool for diagnosis and prognosis of human Chagas' disease. Clin Diagn Lab Immunol 8: 112-118.
7. Correa-Oliveira R, Gomes J, Lemos EM, Cardoso GM, Reis DD, Adad S, Crema E, Martins-Filho OA, Costa MO, Gazzinelli G, Bahia-Oliveira LM 1999. The role of the immune response on the development of severe clinical forms of human Chagas disease. Mem Inst Oswaldo Cruz 94: 253-255.
8. Dutra WO, Gollob KJ 2008. Current concepts in immunoregulation and pathology of human Chagas disease. Curr Opin Infect Dis 21: 287-292.
9. Dutra WO, Gollob KJ, Pinto-Dias JC, Gazzinelli G, Correa-Oliveira R, Coffman RL, Carvalho-Parra JF 1997. Cytokine mRNA profile of peripheral blood mononuclear cells isolated from individuals with Trypanosoma cruzi chronic infection. Scand J Immunol 45: 74-80.
10. Dutra WO, Rocha MO, Teixeira MM 2005. The clinical immunology of human Chagas disease. Trends Parasitol 21: 581-587.
11. Fanger MW, Segal DM, Romet-Lemonne JL 1991. Bispecific antibodies and targeted cellular cytotoxicity. Immunol Today 12: 51-54.
12. Ferreira RC, Ianni BM, Abel LC, Buck P, Mady C, Kalil J, Cunha-Neto E 2003. Increased plasma levels of tumor necrosis factoralpha in asymptomatic/"indeterminate" and Chagas disease cardiomyopathy patients. Mem Inst Oswaldo Cruz 98: 407-411.
13. Gaze ST, Dutra WO, Lessa M, Lessa H, Guimaraes LH, Jesus AR, Carvalho LP, Machado P, Carvalho EM, Gollob KJ 2006. Mucosal leishmaniasis patients display an activated inflammatory T-cell phenotype associated with a nonbalanced monocyte population. Scand J Immunol 63: 70-78.
14. Giordanengo L, Maldonado C, Rivarola HW, Iosa D, Girones N, Fresno M, Gea S 2000. Induction of antibodies reactive to cardiac myosin and development of heart alterations in cruzipain-immunized mice and their offspring. Eur J Immunol 30: 3181-3189.
15. Gomes JA, Bahia-Oliveira LM, Rocha MO, Busek SC, Teixeira MM, Silva JS, Correa-Oliveira R 2005. Type 1 chemokine receptor expression in Chagas' disease correlates with morbidity in cardiac patients. Infect Immun 73: 7960-7966.
16. Gomes JA, Bahia-Oliveira LM, Rocha MO, Martins-Filho OA, Gazzinelli G, Correa-Oliveira R 2003. Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response. Infect Immun 71: 1185-1193.
17. Guedes PM, Veloso VM, Gollob KJ, Afonso LC, Caldas IS, Vianna P, Lana M, Chiari E, Bahia MT, Galvao LM 2008. IgG isotype profile is correlated with cardiomegaly in Beagle dogs infected with distinct Trypanosoma cruzi strains. Vet Immunol Immunopathol 124: 163-168.
18. Higuchi ML, Benvenuti LA, Martins Reis M, Metzger M 2003. Pathophysiology of the heart in Chagas' disease: current status and new developments. Cardiovasc Res 60: 96-107
19. Holscher C, Kohler G, Muller U, Mossmann H, Schaub GA, Brombacher F 1998. Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase. Infect Immun 66: 1208-1215.
20. Kawano Y, Noma T, Yata J 1994. Regulation of human IgG subclass production by cytokines. IFN-gamma and IL-6 act antagonistically in the induction of human IgG1 but additively in the induction of IgG2. J Immunol 153: 4948-4958.
21. Michailowsky V, Luhrs K, Rocha MO, Fouts D, Gazzinelli RT, Manning JE 2003. Humoral and cellular immune responses to Trypanosoma cruzi-derived paraflagellar rod proteins in patients with Chagas' disease. Infect Immun 71: 3165-3171.
22. Moretti E, Basso B, Cervetta L, Brigada A, Barbieri G 2002. Patterns of cytokines and soluble cellular receptors in the sera of children with acute Chagas' disease. Clin Diagn Lab Immunol 9: 1324-1327.
23. Morgan J, Dias JC, Gontijo ED, Bahia-Oliveira L, Correa-Oliveira R, Colley DG, Powell MR 1996. Anti-Trypanosoma cruzi antibody isotype profiles in patients with different clinical manifestations of Chagas' disease. Am J Trop Med Hyg 55: 355-359.
24. Perez-Fuentes R, Lopez-Colombo A, Ordonez-Toquero G, Gomez-Albino I, Ramos J, Torres-Rasgado E, Salgado-Rosas H, Romero-Diaz M, Pulido-Perez P, Sanchez-Guillen MC 2007. Correlation of the serum concentrations of tumour necrosis factor and nitric oxide with disease severity in chronic Chagas disease (American trypanosomiasis). Ann Trop Med Parasitol 101: 123-132.
25. Perez-Fuentes R, Torres-Rasgado E, Salgado-Rosas H, Zamora-Ginez I, Sanchez Guillen MC 2008. The anti-oxidant defence response in individuals with the indeterminate form of Chagas disease (American trypanosomiasis). Ann Trop Med Parasitol 102: 189-197.
26. Ribeirao M, Pereira-Chioccola VL, Renia L, Augusto Fragata Filho A, Schenkman S, Rodrigues MM 2000. Chagasic patients develop a type 1 immune response to Trypanosoma cruzi transsialidase. Parasite Immunol 22: 49-53.
27. Silva JS, Morrissey PJ, Grabstein KH, Mohler KM, Anderson D, Reed SG 1992. Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection. J Exp Med 175: 169-174.
28. Talvani A, Rocha MO, Barcelos LS, Gomes YM, Ribeiro AL, Teixeira MM 2004. Elevated concentrations of CCL2 and tumor necrosis factor-alpha in chagasic cardiomyopathy. Clin Infect Dis 38: 943-950.
29. Tibbetts RS, McCormick TS, Rowland EC, Miller SD, Engman DM 1994. Cardiac antigen-specific autoantibody production is associated with cardiomyopathy in Trypanosoma cruzi-infected mice. J Immunol 152: 1493-1499.
30. Voller A, Bidwell DE, Bartlett A 1976. Enzyme immunoassays in diagnostic medicine. Theory and practice. Bull World Health Organ 53: 55-65.
31. Ward LS, Guariento ME, Fernandes GA, Maciel RM 1999. Serum cytokines in chronic Chagas' disease. Rev Soc Bras Med Trop 32: 285-289.
32. Watthanakulpanich D, Smith HV, Hobbs G, Whalley AJ, Billington D 2008. Application of Toxocara canis excretory-secretory antigens and IgG subclass antibodies (IgG1-4) in serodiagnostic assays of human toxocariasis. Acta Trop 106: 90-95.
33. Zhang L, Tarleton RL 1996. Characterization of cytokine production in murine Trypanosoma cruzi infection by in situ immunocytochemistry: lack of association between susceptibility and type 2 cytokine production. Eur J Immunol 26: 102-109.